Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma
Krug, L.M, Wozniak, A.J, Kindler, H.L, Feld, R, Koczywas, M, Morero, J.L, Rodriguez, C.P, Ross, H.J, Bauman, J.E, Orlov, S.V, Ruckdeschel, J.C, Mita, A.C, Fein, L, He, X, Hall, R, Kawabe, T, Sharma, S
Published in Lung cancer (Amsterdam, Netherlands) (01.09.2014)
Published in Lung cancer (Amsterdam, Netherlands) (01.09.2014)
Get full text
Journal Article
424 POSTER ANG1005, an Angiopep-2/paclitaxel conjugate: the first clinical trial in patients with advanced cancer and brain metastases: Preliminary safety and tolerability data
Kurzrock, R, Fu, S, Mita, A.C, Guo, Z, Allison, C, Bouchard, D, Elian, K.M, Neale, A, Castaigne, J.P, Sarantopoulos, J
Published in European journal of cancer supplements (2008)
Published in European journal of cancer supplements (2008)
Get full text
Journal Article
SARS-CoV-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment
Figueiredo, J.C., Ihenacho, U., Merin, N.M., Hamid, O., Darrah, J., Gong, J., Paquette, R., Mita, A.C., Vescio, R., Mehmi, I., Basho, R., Salvy, S.J., Shirazipour, C.H., Caceres, N., Finster, L.J., Coleman, B., Arnow, H.U., Florindez, L., Sobhani, K., Prostko, J.C., Frias, E.C., Stewart, J.L., Merchant, A., Reckamp, K.L.
Published in Annals of oncology (01.01.2022)
Published in Annals of oncology (01.01.2022)
Get full text
Journal Article
1543TiP - Phase I/II Study to Assess the Safety, Pharmacokinetics (PK) and Efficacy of Lorvotuzumab Mertansine (LM, IMGN901) in Combination with Carboplatin/Etoposide in Patients with Solid Tumors Including Small-Cell Lung Cancer (SCLC)
Spigel, D.R., Bendell, J., Mita, A.C., Argiris, A., Kurkjian, C., Hann, C.L., Segota, Z., Guild, R., Mastico, R., Guiterrez, M.E.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
Final Results of a Phase 2, Open-Label Study of Ramucirumab (IMC-1121B; RAM), an IGG1 MAB Targeting Vegfr-2, with Paclitaxel and Carboplatin as First-Line Therapy in Patients (PTS) with Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) (NCT00735696)
Camidge, D.R., Doebele, R.C., Ballas, M., Jahan, T., Haigentz, M., Hoffman, D., Spicer, J., West, H., Yurasov, S., Mita, A.C.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
Phase I/II Study to Assess the Safety, Pharmacokinetics (PK) and Efficacy of Lorvotuzumab Mertansine (LM, IMGN901) in Combination with Carboplatin/Etoposide in Patients with Solid Tumors Including Small-Cell Lung Cancer (SCLC)
Spigel, D.R., Bendell, J., Mita, A.C., Argiris, A., Kurkjian, C., Hann, C.L., Segota, Z., Guild, R., Mastico, R., Guiterrez, M.E.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
29LB1 Late Breaking ORAL Final safety, pharmacokinetic and antitumor activity results of a phase I study of YM155, a novel survivin inhibitor, when administered by 168 hour continuous infusion
Mita, A.C., Antonia, S., Lewis, L.D., Mahany, J.J., Reddy, N.J., Ricart, A., Till, E., Buell, D., Keating, A.T., Tolcher, A.W.
Published in European journal of cancer supplements (01.11.2006)
Published in European journal of cancer supplements (01.11.2006)
Get full text
Journal Article